Amir Blatt, co-founder and previous CEO of healthtech investment firm Almeda Ventures, has joined Johnson & Johnson – Innovation, JJDC’s EMEA team.
Pharmaceutical firm Johnson & Johnson’s corporate venture capital arm, Johnson & Johnson Innovation – JJDC, has hired Amir Blatt as the latest investor on its Europe, Middle East and Africa (EMEA) team.
Israel-based Blatt had previously targeted medical device and digital health technology developers as co-founder of healthtech investment firm Almeda Ventures, initially as founding partner and chief investment officer, before he took on the CEO role in 2024.
“[I am] thrilled to work with an incredible group to support visionary entrepreneurs and advance innovations that can transform healthcare globally,” Blatt said in a LinkedIn post announcing the move.
“Looking forward to collaborating with founders, investors and partners across the ecosystem to bring groundbreaking ideas to life.”
Blatt will continue to support Almeda’s portfolio companies as founding partner but will no longer have an operational role at the firm. It co-led a $13m round for robotic surgery tool developer FlexDex in 2021 with JJDC.
Want a snapshot of Johnson & Johnson – Innovation, JJDC’s most recent investments? Check out GCV’s CVC Funding Round Database
